Live Chat

CFD’er er komplekse instrumenter, og der er en stor risiko forbundet med disse for at miste penge på grund af gearing. 76,3% af detailinvestorerne har tab på deres konto, når de handler CFD’er med denne udbyder.Du skal overveje, om du forstår, hvordan CFD’er fungerer, og om du har råd til at løbe en stor risiko for at miste dine penge.

Close

Handel AstraZeneca AZN

AstraZeneca live diagram

Indsigt

Weekly Search
Weekly
Daily
date Luk change % Ændre Åbn Høj Lav

Markets.com news

New Zealand dollar drops on unexpected dovish tone from RBNZ
Georgy Istigechev 2024 Jul 10, 10:00

Unexpected dovish tone from RBNZ drops New Zealand dollar

Forex Indices USD
Sterling steady as investors take in UK, French election results
Georgy Istigechev 2024 Jul 09, 10:15

Sterling steady near one-month high in wake of UK election

Forex Indices GBP USD EUR
BP shares fall on Q2 profit warning
Georgy Istigechev 2024 Jul 09, 10:00

BP shares drop over 4% on Q2 lower profit warning

Shares Indices Oil FTSE100
BP shares dip ahead of Powell Congress testimony
Neil Wilson 2024 Jul 09, 07:30

BP dips, Powell Congress speech ahead, records for Tokyo, NY

Shares Indices Forex Commodities

Info

Spread

68.43

Spread (%)

0.6598 %

Gearing

1:5

Dag til dag-rente Køb

-0.0590 %

Dag til dag-rente Sælg

-0.0299 %

Valuta

PNC

Åbningstider for handel

Market lukket

Tirsdag

08:01 - 11:59

Mandag

08:01-11:59

Mandag

12:03-16:29

Onsdag

08:01-11:59

Onsdag

12:03-16:29

Torsdag

08:01-11:59

Torsdag

12:03-16:29

Fredag

08:01-11:59

Fredag

12:03-16:29

Resultatopgørelse

Åbn

---

Forrige luk

---

52 uger høj/lav

--- – ---

Markedsværdi

161574354944

Aktier udestående

1550320000

Indtjeningsdato (Næste)

0000-00-00

instr__dividend_date

instr__ex_dividend_date

2024-08-08

instr__forward_annual_dividend_rate

2.34

instr__forward_annual_dividend_yield

0.0228

EPS

3.26

Aktier Udestående

AstraZeneca AstraZeneca PLC
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology. Its marketed products also comprise Vaxzevria, Beyfortus, Synagis, FluMist, Soliris, Ultomiris, Strensiq, Koselugo, and Kanuma for covid-19 and rare disease. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Neurimmune AG to develop and commercialize NI006; BenevolentAI for drug discovery for systemic lupus erythematosus; Lunit for developing AI-Powered Digital Pathology Risk Assessment Tools for NSCLC; and Absci Corporation for AI-driven drug discovery against an oncology target. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.

Få mere at vide om dette instrument

Aktiv
Sælge
Køb
% Ændre
Relaterede instrumenter
Trustpilot
Live Chat